Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.

PubWeight™: 4.00‹?› | Rank: Top 1%

🔗 View Article (PMID 28304219)

Published in N Engl J Med on March 17, 2017

Authors

Michael J Reardon1, Nicolas M Van Mieghem1, Jeffrey J Popma1, Neal S Kleiman1, Lars Søndergaard1, Mubashir Mumtaz1, David H Adams1, G Michael Deeb1, Brijeshwar Maini1, Hemal Gada1, Stanley Chetcuti1, Thomas Gleason1, John Heiser1, Rüdiger Lange1, William Merhi1, Jae K Oh1, Peter S Olsen1, Nicolo Piazza1, Mathew Williams1, Stephan Windecker1, Steven J Yakubov1, Eberhard Grube1, Raj Makkar1, Joon S Lee1, John Conte1, Eric Vang1, Hang Nguyen1, Yanping Chang1, Andrew S Mugglin1, Patrick W J C Serruys1, Arie P Kappetein1, SURTAVI Investigators

Author Affiliations

1: From Methodist DeBakey Heart and Vascular Center, Houston (M.J.R., N.S.K.); Erasmus University Medical Center, Rotterdam, the Netherlands (N.M.V.M., P.W.J.C.S., A.P.K.); Beth Israel Deaconess Medical Center, Boston (J.J.P.); the Heart Center, Rigshospitalet, Copenhagen (L.S., P.S.O.); PinnacleHealth Hospitals, Harrisburg (M.M., H.G.), and University of Pittsburgh Medical Center, Pittsburgh (T.G., J.S.L.) - both in Pennsylvania; Mount Sinai Health System (D.H.A.) and New York University Langone Medical Center (M.W.) - both in New York; University of Michigan, Ann Arbor (G.M.D., S.C.), and Spectrum Health Hospitals, Grand Rapids (J.H., W.M.) - both in Michigan; Tenet Healthcare, Delray Beach, FL (B.M.); German Heart Center Munich, Munich (R.L.), and Siegburg Heart Center, Siegburg (E.G.) - both in Germany; Mayo Clinic, Rochester (J.K.O.), Medtronic, Minneapolis (E.V., H.N., Y.C.), and Paradigm Biostatistics, Anoka (A.S.M.) - all in Minnesota; McGill University Medical Centre, Montreal (N.P.); University Hospital Bern, Bern, Switzerland (S.W.); Riverside Methodist Hospital, Columbus, OH (S.J.Y.); Cedars-Sinai Medical Center, Los Angeles (R.M.); and Johns Hopkins University, Baltimore (J.C.).

Associated clinical trials:

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). (SURTAVI) | NCT01586910